Teradyne director Matz proposes $273K share sale
The notice also lists four earlier sales between July 15 and September 17, 2026, in its prior-three-month sales section.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Teradyne, Inc. director Marilyn Matz reported a proposed sale of 800 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $273,024.00 and a proposed sale date of October 15, 2026. The notice lists the shares as acquired through restricted-stock vesting: 44 shares on May 7, 2021, and 756 shares on May 9, 2024. It lists 156,340,750 shares outstanding.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior sales does Marilyn Matz report for TER?
AI-generated analysis. How Rhea-AI works. Not financial advice.